Information, Marketing, and Pricing in the U.S. Antiulcer Drug Market

The role of information in facilitating and explaining growth of the overall antiulcer drug market, as well as in shaping the changing market shares of 4 patented antiulcer drugs - Tagamet, Zantac, Pepcid and Axid - is examined empirically. The dissemination of information is due largely to the use...

Full description

Saved in:
Bibliographic Details
Published in:The American economic review 1995-05, Vol.85 (2), p.100-105
Main Authors: Berndt, Ernst R., Bui, Linda, Reiley, David R., Urban, Glen L.
Format: Article
Language:English
Subjects:
Advertising
Anti-Ulcer Agents - economics
Drug Costs
Econometrics
Economic models
Economic theory
Health technology assessment
Histamine H2 Antagonists - economics
Humans
Industrial market
Industrial marketing
Industry
Information
Information dissemination
Information, Educating, and Marketing in Health Care
Market demand
Market prices
Market share
Market shares
Marketing
Marketing of Health Services
Models, Econometric
Peptic Ulcer - drug therapy
Pharmaceutical industry
Pharmaceuticals
Prescription drugs
Price elasticity
Price elasticity of demand
Prices
Pricing
Product differentiation
Studies
U.S.A
Ulcers
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 105
container_issue 2
container_start_page 100
container_title The American economic review
container_volume 85
creator Berndt, Ernst R.
Bui, Linda
Reiley, David R.
Urban, Glen L.
description The role of information in facilitating and explaining growth of the overall antiulcer drug market, as well as in shaping the changing market shares of 4 patented antiulcer drugs - Tagamet, Zantac, Pepcid and Axid - is examined empirically. The dissemination of information is due largely to the use of marketing channels, such as visits by manufacturers' representatives to physicians, advertising in medical journals, and most recently, by direct-to-consumer advertising. These are examined and pricing policies, product differentiation, and order-of-entry effects are explored.
format article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_77940788</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>2117900</jstor_id><sourcerecordid>2117900</sourcerecordid><originalsourceid>FETCH-LOGICAL-g376t-d5ccd92a7302f6026799a3139a761ad740556e3818b300e41b25cdb78916d8073</originalsourceid><addsrcrecordid>eNqF0E1Lw0AQBuBFFFur_0BkUfDUlNmdZD-Opa1aqChoz2GTbGtqsqmb5OC_N9rqQRBPw8s8MzBzQPpMh2EgtWKHpA8APFBc8R45qesNfGYmj0mPARMQMd0ns7lbVb40TV65Ib03_tU2uVsPqXEZffR52gWaO9q8WLocPY3o2DV5W6TW06lv1_uJU3K0MkVtz_Z1QJY3s-fJXbB4uJ1PxotgjVI0QRalaaa5kQh8JYALqbVBhtpIwUwmQ4giYVExlSCADVnCozRLpNJMZAokDsj1bu_WV2-trZu4zOvUFoVxtmrrWEodglTqX4hKKuRf8PIX3FStd90RMUcEjIBDh67-QowrLSDUiJ262Ks2KW0Wb31eGv8efz-7A-c7sKmbyv_0OWNSA-AH6iKAQg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>233035020</pqid></control><display><type>article</type><title>Information, Marketing, and Pricing in the U.S. Antiulcer Drug Market</title><source>EBSCOhost Business Source Ultimate</source><source>International Bibliography of the Social Sciences (IBSS)</source><source>EBSCOhost Econlit with Full Text</source><source>JSTOR Archival Journals and Primary Sources Collection</source><source>Social Science Premium Collection</source><source>ABI/INFORM Global</source><creator>Berndt, Ernst R. ; Bui, Linda ; Reiley, David R. ; Urban, Glen L.</creator><creatorcontrib>Berndt, Ernst R. ; Bui, Linda ; Reiley, David R. ; Urban, Glen L.</creatorcontrib><description>The role of information in facilitating and explaining growth of the overall antiulcer drug market, as well as in shaping the changing market shares of 4 patented antiulcer drugs - Tagamet, Zantac, Pepcid and Axid - is examined empirically. The dissemination of information is due largely to the use of marketing channels, such as visits by manufacturers' representatives to physicians, advertising in medical journals, and most recently, by direct-to-consumer advertising. These are examined and pricing policies, product differentiation, and order-of-entry effects are explored.</description><identifier>ISSN: 0002-8282</identifier><identifier>EISSN: 1944-7981</identifier><identifier>PMID: 10160519</identifier><identifier>CODEN: AENRAA</identifier><language>eng</language><publisher>United States: American Economic Association</publisher><subject>Advertising ; Anti-Ulcer Agents - economics ; Drug Costs ; Econometrics ; Economic models ; Economic theory ; Health technology assessment ; Histamine H2 Antagonists - economics ; Humans ; Industrial market ; Industrial marketing ; Industry ; Information ; Information dissemination ; Information, Educating, and Marketing in Health Care ; Market demand ; Market prices ; Market share ; Market shares ; Marketing ; Marketing of Health Services ; Models, Econometric ; Peptic Ulcer - drug therapy ; Pharmaceutical industry ; Pharmaceuticals ; Prescription drugs ; Price elasticity ; Price elasticity of demand ; Prices ; Pricing ; Product differentiation ; Studies ; U.S.A ; Ulcers</subject><ispartof>The American economic review, 1995-05, Vol.85 (2), p.100-105</ispartof><rights>Copyright 1995 American Economic Association</rights><rights>Copyright American Economic Association May 1995</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/233035020/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/233035020?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,11688,12847,21394,33223,33224,33611,33612,36060,36061,43733,44363,58238,58471,74221,74895</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10160519$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berndt, Ernst R.</creatorcontrib><creatorcontrib>Bui, Linda</creatorcontrib><creatorcontrib>Reiley, David R.</creatorcontrib><creatorcontrib>Urban, Glen L.</creatorcontrib><title>Information, Marketing, and Pricing in the U.S. Antiulcer Drug Market</title><title>The American economic review</title><addtitle>Am Econ Rev</addtitle><description>The role of information in facilitating and explaining growth of the overall antiulcer drug market, as well as in shaping the changing market shares of 4 patented antiulcer drugs - Tagamet, Zantac, Pepcid and Axid - is examined empirically. The dissemination of information is due largely to the use of marketing channels, such as visits by manufacturers' representatives to physicians, advertising in medical journals, and most recently, by direct-to-consumer advertising. These are examined and pricing policies, product differentiation, and order-of-entry effects are explored.</description><subject>Advertising</subject><subject>Anti-Ulcer Agents - economics</subject><subject>Drug Costs</subject><subject>Econometrics</subject><subject>Economic models</subject><subject>Economic theory</subject><subject>Health technology assessment</subject><subject>Histamine H2 Antagonists - economics</subject><subject>Humans</subject><subject>Industrial market</subject><subject>Industrial marketing</subject><subject>Industry</subject><subject>Information</subject><subject>Information dissemination</subject><subject>Information, Educating, and Marketing in Health Care</subject><subject>Market demand</subject><subject>Market prices</subject><subject>Market share</subject><subject>Market shares</subject><subject>Marketing</subject><subject>Marketing of Health Services</subject><subject>Models, Econometric</subject><subject>Peptic Ulcer - drug therapy</subject><subject>Pharmaceutical industry</subject><subject>Pharmaceuticals</subject><subject>Prescription drugs</subject><subject>Price elasticity</subject><subject>Price elasticity of demand</subject><subject>Prices</subject><subject>Pricing</subject><subject>Product differentiation</subject><subject>Studies</subject><subject>U.S.A</subject><subject>Ulcers</subject><issn>0002-8282</issn><issn>1944-7981</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>8BJ</sourceid><sourceid>ALSLI</sourceid><sourceid>M0C</sourceid><sourceid>M2R</sourceid><recordid>eNqF0E1Lw0AQBuBFFFur_0BkUfDUlNmdZD-Opa1aqChoz2GTbGtqsqmb5OC_N9rqQRBPw8s8MzBzQPpMh2EgtWKHpA8APFBc8R45qesNfGYmj0mPARMQMd0ns7lbVb40TV65Ib03_tU2uVsPqXEZffR52gWaO9q8WLocPY3o2DV5W6TW06lv1_uJU3K0MkVtz_Z1QJY3s-fJXbB4uJ1PxotgjVI0QRalaaa5kQh8JYALqbVBhtpIwUwmQ4giYVExlSCADVnCozRLpNJMZAokDsj1bu_WV2-trZu4zOvUFoVxtmrrWEodglTqX4hKKuRf8PIX3FStd90RMUcEjIBDh67-QowrLSDUiJ262Ks2KW0Wb31eGv8efz-7A-c7sKmbyv_0OWNSA-AH6iKAQg</recordid><startdate>19950501</startdate><enddate>19950501</enddate><creator>Berndt, Ernst R.</creator><creator>Bui, Linda</creator><creator>Reiley, David R.</creator><creator>Urban, Glen L.</creator><general>American Economic Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>EOLOZ</scope><scope>FKUCP</scope><scope>HZAIM</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope><scope>0-V</scope><scope>3V.</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88C</scope><scope>88E</scope><scope>88J</scope><scope>8BJ</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FQK</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>JBE</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>L.-</scope><scope>M0C</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M2R</scope><scope>MBDVC</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>19950501</creationdate><title>Information, Marketing, and Pricing in the U.S. Antiulcer Drug Market</title><author>Berndt, Ernst R. ; Bui, Linda ; Reiley, David R. ; Urban, Glen L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g376t-d5ccd92a7302f6026799a3139a761ad740556e3818b300e41b25cdb78916d8073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Advertising</topic><topic>Anti-Ulcer Agents - economics</topic><topic>Drug Costs</topic><topic>Econometrics</topic><topic>Economic models</topic><topic>Economic theory</topic><topic>Health technology assessment</topic><topic>Histamine H2 Antagonists - economics</topic><topic>Humans</topic><topic>Industrial market</topic><topic>Industrial marketing</topic><topic>Industry</topic><topic>Information</topic><topic>Information dissemination</topic><topic>Information, Educating, and Marketing in Health Care</topic><topic>Market demand</topic><topic>Market prices</topic><topic>Market share</topic><topic>Market shares</topic><topic>Marketing</topic><topic>Marketing of Health Services</topic><topic>Models, Econometric</topic><topic>Peptic Ulcer - drug therapy</topic><topic>Pharmaceutical industry</topic><topic>Pharmaceuticals</topic><topic>Prescription drugs</topic><topic>Price elasticity</topic><topic>Price elasticity of demand</topic><topic>Prices</topic><topic>Pricing</topic><topic>Product differentiation</topic><topic>Studies</topic><topic>U.S.A</topic><topic>Ulcers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berndt, Ernst R.</creatorcontrib><creatorcontrib>Bui, Linda</creatorcontrib><creatorcontrib>Reiley, David R.</creatorcontrib><creatorcontrib>Urban, Glen L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Periodicals Index Online Segment 01</collection><collection>Periodicals Index Online Segment 04</collection><collection>Periodicals Index Online Segment 26</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access &amp; Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access &amp; Build (Plan A) - APAC</collection><collection>Primary Sources Access &amp; Build (Plan A) - Canada</collection><collection>Primary Sources Access &amp; Build (Plan A) - West</collection><collection>Primary Sources Access &amp; Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access &amp; Build (Plan A) - Midwest</collection><collection>Primary Sources Access &amp; Build (Plan A) - North Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - Northeast</collection><collection>Primary Sources Access &amp; Build (Plan A) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health &amp; Medical Complete (ProQuest Database)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>International Bibliography of the Social Sciences</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>International Bibliography of the Social Sciences</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Global</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library (ProQuest Database)</collection><collection>Social Science Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American economic review</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berndt, Ernst R.</au><au>Bui, Linda</au><au>Reiley, David R.</au><au>Urban, Glen L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Information, Marketing, and Pricing in the U.S. Antiulcer Drug Market</atitle><jtitle>The American economic review</jtitle><addtitle>Am Econ Rev</addtitle><date>1995-05-01</date><risdate>1995</risdate><volume>85</volume><issue>2</issue><spage>100</spage><epage>105</epage><pages>100-105</pages><issn>0002-8282</issn><eissn>1944-7981</eissn><coden>AENRAA</coden><abstract>The role of information in facilitating and explaining growth of the overall antiulcer drug market, as well as in shaping the changing market shares of 4 patented antiulcer drugs - Tagamet, Zantac, Pepcid and Axid - is examined empirically. The dissemination of information is due largely to the use of marketing channels, such as visits by manufacturers' representatives to physicians, advertising in medical journals, and most recently, by direct-to-consumer advertising. These are examined and pricing policies, product differentiation, and order-of-entry effects are explored.</abstract><cop>United States</cop><pub>American Economic Association</pub><pmid>10160519</pmid><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-8282
ispartof The American economic review, 1995-05, Vol.85 (2), p.100-105
issn 0002-8282
1944-7981
language eng
recordid cdi_proquest_miscellaneous_77940788
source EBSCOhost Business Source Ultimate; International Bibliography of the Social Sciences (IBSS); EBSCOhost Econlit with Full Text; JSTOR Archival Journals and Primary Sources Collection; Social Science Premium Collection; ABI/INFORM Global
subjects Advertising
Anti-Ulcer Agents - economics
Drug Costs
Econometrics
Economic models
Economic theory
Health technology assessment
Histamine H2 Antagonists - economics
Humans
Industrial market
Industrial marketing
Industry
Information
Information dissemination
Information, Educating, and Marketing in Health Care
Market demand
Market prices
Market share
Market shares
Marketing
Marketing of Health Services
Models, Econometric
Peptic Ulcer - drug therapy
Pharmaceutical industry
Pharmaceuticals
Prescription drugs
Price elasticity
Price elasticity of demand
Prices
Pricing
Product differentiation
Studies
U.S.A
Ulcers
title Information, Marketing, and Pricing in the U.S. Antiulcer Drug Market
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T16%3A18%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Information,%20Marketing,%20and%20Pricing%20in%20the%20U.S.%20Antiulcer%20Drug%20Market&rft.jtitle=The%20American%20economic%20review&rft.au=Berndt,%20Ernst%20R.&rft.date=1995-05-01&rft.volume=85&rft.issue=2&rft.spage=100&rft.epage=105&rft.pages=100-105&rft.issn=0002-8282&rft.eissn=1944-7981&rft.coden=AENRAA&rft_id=info:doi/&rft_dat=%3Cjstor_proqu%3E2117900%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g376t-d5ccd92a7302f6026799a3139a761ad740556e3818b300e41b25cdb78916d8073%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=233035020&rft_id=info:pmid/10160519&rft_jstor_id=2117900&rfr_iscdi=true